RAE1
gene geneOn this page
Also known as Mnrp41Gle2
Summary
RAE1 (ribonucleic acid export 1, HGNC:9828) is a protein-coding gene on chromosome 20q13.31, encoding mRNA export factor RAE1 (P78406). Acts as a mRNA export factor involved in nucleocytoplasmic transport. It is a common-essential gene (DepMap: required in 99.7% of cancer cell lines).
Mutations in the Schizosaccharomyces pombe Rae1 and Saccharomyces cerevisiae Gle2 genes have been shown to result in accumulation of poly(A)-containing mRNA in the nucleus, suggesting that the encoded proteins are involved in RNA export. The protein encoded by this gene is a homolog of yeast Rae1. It contains four WD40 motifs, and has been shown to localize to distinct foci in the nucleoplasm, to the nuclear rim, and to meshwork-like structures throughout the cytoplasm. This gene is thought to be involved in nucleocytoplasmic transport, and in directly or indirectly attaching cytoplasmic mRNPs to the cytoskeleton. Alternatively spliced transcript variants encoding the same protein have been found for this gene.
Source: NCBI Gene 8480 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 23 total
- Druggable target: yes
- Cancer dependency (DepMap): dependent in 99.7% of screened cell lines (common-essential)
- MANE Select transcript:
NM_003610
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:9828 |
| Approved symbol | RAE1 |
| Name | ribonucleic acid export 1 |
| Location | 20q13.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Mnrp41, Gle2 |
| Ensembl gene | ENSG00000101146 |
| Ensembl biotype | protein_coding |
| OMIM | 603343 |
| Entrez | 8480 |
Gene structure
Transcript identifiers
Ensembl transcripts: 14 — 12 protein_coding, 1 retained_intron, 1 nonsense_mediated_decay
ENST00000371242, ENST00000395840, ENST00000395841, ENST00000411894, ENST00000429339, ENST00000452119, ENST00000462438, ENST00000492498, ENST00000527947, ENST00000857607, ENST00000922549, ENST00000922550, ENST00000947294, ENST00000947295
RefSeq mRNA: 2 — MANE Select: NM_003610
NM_001015885, NM_003610
CCDS: CCDS13458
Canonical transcript exons
ENST00000395841 — 12 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000662941 | 57354712 | 57354816 |
| ENSE00000845744 | 57356446 | 57356538 |
| ENSE00000907050 | 57365356 | 57365442 |
| ENSE00000907051 | 57366807 | 57366893 |
| ENSE00000907052 | 57367008 | 57367079 |
| ENSE00000907053 | 57368705 | 57368812 |
| ENSE00000907054 | 57373475 | 57373581 |
| ENSE00001454763 | 57351255 | 57351422 |
| ENSE00002186563 | 57354032 | 57354128 |
| ENSE00003469125 | 57374607 | 57374801 |
| ENSE00003653699 | 57373663 | 57373738 |
| ENSE00003845672 | 57378013 | 57379202 |
Expression profiles
Bgee: expression breadth ubiquitous, 281 present calls, max score 98.73.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 53.9824 / max 288.6944, expressed in 1824 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 185467 | 53.7838 | 1824 |
| 185469 | 0.1661 | 4 |
| 185468 | 0.0228 | 8 |
| 185470 | 0.0098 | 3 |
Top tissues by expression
290 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| secondary oocyte | CL:0000655 | 98.73 | gold quality |
| sperm | CL:0000019 | 97.79 | gold quality |
| oocyte | CL:0000023 | 97.75 | gold quality |
| endometrium epithelium | UBERON:0004811 | 97.24 | gold quality |
| male germ cell | CL:0000015 | 97.11 | gold quality |
| adult organism | UBERON:0007023 | 96.50 | gold quality |
| left testis | UBERON:0004533 | 96.47 | gold quality |
| right testis | UBERON:0004534 | 96.41 | gold quality |
| testis | UBERON:0000473 | 95.86 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 94.14 | gold quality |
| medial globus pallidus | UBERON:0002477 | 93.68 | gold quality |
| embryo | UBERON:0000922 | 93.58 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 93.46 | gold quality |
| cortical plate | UBERON:0005343 | 92.76 | gold quality |
| ganglionic eminence | UBERON:0004023 | 92.63 | gold quality |
| bone marrow | UBERON:0002371 | 92.54 | gold quality |
| ventricular zone | UBERON:0003053 | 92.48 | gold quality |
| amniotic fluid | UBERON:0000173 | 92.16 | gold quality |
| oral cavity | UBERON:0000167 | 92.06 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 91.88 | silver quality |
| globus pallidus | UBERON:0001875 | 91.74 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 91.72 | gold quality |
| endothelial cell | CL:0000115 | 91.64 | gold quality |
| penis | UBERON:0000989 | 91.38 | gold quality |
| squamous epithelium | UBERON:0006914 | 91.20 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 91.02 | gold quality |
| epithelium of esophagus | UBERON:0001976 | 90.78 | gold quality |
| parotid gland | UBERON:0001831 | 90.48 | gold quality |
| gingiva | UBERON:0001828 | 90.32 | gold quality |
| thymus | UBERON:0002370 | 90.32 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): AP1
miRNA regulators (miRDB)
25 targeting RAE1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-8087 | 99.90 | 69.55 | 1351 |
| HSA-MIR-548AJ-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548F-5P | 99.78 | 71.02 | 3093 |
| HSA-MIR-548G-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548X-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-556-3P | 99.74 | 68.75 | 1203 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-7161-5P | 99.68 | 68.92 | 1592 |
| HSA-MIR-548U | 99.65 | 67.78 | 1463 |
| HSA-MIR-1827 | 99.63 | 68.57 | 3265 |
| HSA-MIR-4437 | 99.52 | 65.29 | 1266 |
| HSA-MIR-185-5P | 99.35 | 68.60 | 2497 |
| HSA-MIR-4644 | 99.35 | 69.12 | 2514 |
| HSA-MIR-4505 | 99.27 | 67.81 | 2678 |
| HSA-MIR-5787 | 99.22 | 67.86 | 2628 |
| HSA-MIR-6504-3P | 99.17 | 69.31 | 2891 |
| HSA-MIR-10399-5P | 99.17 | 69.87 | 2610 |
| HSA-MIR-2276-3P | 98.76 | 67.75 | 1384 |
| HSA-MIR-4772-3P | 98.04 | 65.60 | 1203 |
| HSA-MIR-5192 | 96.89 | 63.35 | 879 |
| HSA-MIR-4640-3P | 94.58 | 63.02 | 263 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 99.7% of screened cell lines, common-essential.
Literature-anchored findings (GeneRIF, showing 24)
- These data show an association of mrnp41 with MT and, moreover, demonstrate that an intact MT system is necessary for dispersion of mrnp41-containing particles to the cellular periphery (PMID:11831386)
- VSV M protein blocks mRNA export by disrupting Rae1 function, which can be reverted by induction of Rae1 expression. (PMID:15629720)
- A purified Rae1 complex stabilizes microtubules in egg extracts in a RanGTP/importin beta-regulated manner (PMID:15851029)
- point to the Rae1-NuMA interaction as a critical element for normal spindle formation in mitosis (PMID:17172455)
- Retinoic acid downregulates Rae1 leading to APC(Cdh1) activation and neuroblastoma SH-SY5Y differentiation. (PMID:18212744)
- Interaction between Rae1 and cohesin subunit SMC1 is required for proper spindle formation. (PMID:20016259)
- present the crystal structure of human Rae1 in complex with the Gle2-binding sequence (GLEBS) of Nup98 at 1.65 A resolution. Rae1 forms a seven-bladed beta-propeller with several extensive surface loops. (PMID:20498086)
- In a transgenic mouse model of chronic natural killer NKG2D ligand expression, constant exposure to NKG2D ligand RNA export 1 homolog (Rae-1 epsilon) does not functionally impair NK cells or CD8-positive T cells in the context of viral infection. (PMID:20530257)
- RAE1 transgene orchestrates proper chromosome segregation and NUP98-mediated leukemogenesis. (PMID:21467841)
- This study established a novel postmitotic function for rae-1 in neuronal development. (PMID:22357847)
- vesicular stomatitis virus M protein interacted efficiently with Rae1-Nup98 complexes associated with the chromatin fraction of host nuclei, consistent with an effect on host transcription (PMID:23028327)
- mouse cytomegalovirus m152/gp40 interaction with RAE1gamma structural analysis reveals a paradigm for MHC/MHC interaction in immune evasion (PMID:23169621)
- Vesiculoviral matrix (M) protein occupies nucleic acid binding site at nucleoporin pair (Rae1 * Nup98). (PMID:24927547)
- Nuclear export inhibition by ORF10 of human herpesvirus 8 requires an interaction with an RNA export factor, Rae1. (PMID:27832591)
- RAE1 overexpression was associated with considerably poorer disease-free survival and distant metastasis-free survival, especially in patients with oestrogen receptor-positive tumours. (PMID:28181567)
- After PSK administration, INF-g production in CD8(+) T cells increased in mice with cells expressing neither Rae-1 nor H60, but did not change in mice implanted with cells expressing both Rae-1 and H60. We demonstrated that the expression of NKG2DLs affects tumor immunity and the efficacy of immuno therapy in tumor-bearing mouse model (PMID:28739693)
- show that USP11 is associated with the mitotic spindle, does not regulate SAC inactivation, but controls ubiquitination of RAE1 at the mitotic spindle, hereby functionally modulating its interaction with Nuclear Mitotic Apparatus protein (NuMA). (PMID:29293652)
- RAE1 and NUP98 participate inBMAL1 shuttling and promote the degradation and activity of BMAL1 and CLOCK. (PMID:30683868)
- Lysine acetylation of NKG2D ligand Rae-1 stabilizes the protein and sensitizes tumor cells to NKG2D immune surveillance. (PMID:33279621)
- Overexpression of SARS-CoV-2 protein ORF6 dislocates RAE1 and NUP98 from the nuclear pore complex. (PMID:33360543)
- Mitotic checkpoint regulator RAE1 promotes tumor growth in colorectal cancer. (PMID:34008277)
- Super-Enhancer-Driven RAE1 Shows Higher Protein Levels in Tumor Compared to Adjacent Nonmalignant Stroma in High-Grade Serous Ovarian Cancer Patients. (PMID:36810690)
- Insights into the SARS-CoV-2 ORF6 Mechanism of Action. (PMID:37511350)
- SARS-CoV-2 Orf6 is positioned in the nuclear pore complex by Rae1 to inhibit nucleocytoplasmic transport. (PMID:38507240)
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | rae1 | ENSDARG00000007196 |
| mus_musculus | Rae1 | ENSMUSG00000027509 |
| rattus_norvegicus | Rae1 | ENSRNOG00000021295 |
| drosophila_melanogaster | Rae1 | FBGN0034646 |
| drosophila_melanogaster | CG12782 | FBGN0034838 |
| caenorhabditis_elegans | rae-1 | WBGENE00003803 |
Paralogs (2): BUB3 (ENSG00000154473), DNAAF10 (ENSG00000243667)
Protein
Protein identifiers
mRNA export factor RAE1 — P78406 (reviewed: P78406)
Alternative names: Rae1 protein homolog, mRNA-associated protein mrnp 41
All UniProt accessions (5): P78406, B0QZ36, B0QZ37, E9PPG9, E9PQ57
UniProt curated annotations — full annotation on UniProt →
Function. Acts as a mRNA export factor involved in nucleocytoplasmic transport. Plays a role in mitotic bipolar spindle formation. May function in attaching cytoplasmic mRNPs to the cytoskeleton both directly or indirectly.
Subunit / interactions. Interacts with NUMA1 (via N-terminal end of the coiled-coil domain); this interaction promotes spindle formation in mitosis. Interacts with NUP98. Interacts with MYCBP2. Interacts with USP11. (Microbial infection) Interacts with SARS coronavirus-2/SARS-CoV-2 ORF6 protein; the interaction displaces RAE1 from the nuclear envelope and impairs its role in nucleocytoplasmic transport. (Microbial infection) Interacts with SARS coronavirus/SARS-CoV ORF6 protein.
Subcellular location. Cytoplasm. Nucleus. Cytoskeleton. Spindle pole. Nucleus envelope.
Similarity. Belongs to the WD repeat rae1 family.
RefSeq proteins (2): NP_001015885, NP_003601* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001680 | WD40_rpt | Repeat |
| IPR015943 | WD40/YVTN_repeat-like_dom_sf | Homologous_superfamily |
| IPR019775 | WD40_repeat_CS | Conserved_site |
| IPR020472 | WD40_PAC1 | Repeat |
| IPR036322 | WD40_repeat_dom_sf | Homologous_superfamily |
Pfam: PF00400
UniProt features (53 total): strand 31, repeat 7, sequence conflict 5, turn 4, helix 3, chain 1, region of interest 1, modified residue 1
Structure
Experimental structures (PDB)
6 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 3MMY | X-RAY DIFFRACTION | 1.65 |
| 7F90 | X-RAY DIFFRACTION | 2.39 |
| 7VPG | X-RAY DIFFRACTION | 2.49 |
| 7VPH | X-RAY DIFFRACTION | 2.8 |
| 7F60 | X-RAY DIFFRACTION | 2.85 |
| 4OWR | X-RAY DIFFRACTION | 3.15 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P78406-F1 | 93.46 | 0.90 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 229
Function
Pathways and Gene Ontology
Reactome pathways
31 pathways
| ID | Pathway |
|---|---|
| R-HSA-1169408 | ISG15 antiviral mechanism |
| R-HSA-159227 | Transport of the SLBP independent Mature mRNA |
| R-HSA-159230 | Transport of the SLBP Dependant Mature mRNA |
| R-HSA-159231 | Transport of Mature mRNA Derived from an Intronless Transcript |
| R-HSA-159236 | Transport of Mature mRNA derived from an Intron-Containing Transcript |
| R-HSA-165054 | Rev-mediated nuclear export of HIV RNA |
| R-HSA-168271 | Transport of Ribonucleoproteins into the Host Nucleus |
| R-HSA-168276 | NS1 Mediated Effects on Host Pathways |
| R-HSA-168325 | Viral Messenger RNA Synthesis |
| R-HSA-168333 | NEP/NS2 Interacts with the Cellular Export Machinery |
| R-HSA-170822 | Regulation of Glucokinase by Glucokinase Regulatory Protein |
| R-HSA-180746 | Nuclear import of Rev protein |
| R-HSA-180910 | Vpr-mediated nuclear import of PICs |
| R-HSA-1855170 | IPs transport between nucleus and cytosol |
| R-HSA-1855196 | IP3 and IP4 transport between cytosol and nucleus |
| R-HSA-1855229 | IP6 and IP7 transport between cytosol and nucleus |
| R-HSA-191859 | snRNP Assembly |
| R-HSA-3108214 | SUMOylation of DNA damage response and repair proteins |
| R-HSA-3232142 | SUMOylation of ubiquitinylation proteins |
| R-HSA-3301854 | Nuclear Pore Complex (NPC) Disassembly |
| R-HSA-3371453 | Regulation of HSF1-mediated heat shock response |
| R-HSA-4085377 | SUMOylation of SUMOylation proteins |
| R-HSA-4551638 | SUMOylation of chromatin organization proteins |
| R-HSA-4570464 | SUMOylation of RNA binding proteins |
| R-HSA-4615885 | SUMOylation of DNA replication proteins |
| R-HSA-5619107 | Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) |
| R-HSA-6784531 | tRNA processing in the nucleus |
| R-HSA-9609690 | HCMV Early Events |
| R-HSA-9610379 | HCMV Late Events |
| R-HSA-9705671 | SARS-CoV-2 activates/modulates innate and adaptive immune responses |
MSigDB gene sets: 203 (showing top):
GOBP_CHROMOSOME_ORGANIZATION, RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP, REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS, GOBP_REGULATION_OF_MICROTUBULE_BASED_PROCESS, MORF_RAB5A, REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM, ENK_UV_RESPONSE_KERATINOCYTE_UP, REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS, CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN, HEIDENBLAD_AMPLICON_8Q24_DN, MORF_PSMC2, GOBP_NUCLEAR_TRANSPORT, REACTOME_HIV_INFECTION, GOBP_REGULATION_OF_SPINDLE_ORGANIZATION, REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA
GO Biological Process (6): transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972), RNA export from nucleus (GO:0006405), mRNA export from nucleus (GO:0006406), nucleocytoplasmic transport (GO:0006913), cell division (GO:0051301), regulation of mitotic spindle organization (GO:0060236)
GO Molecular Function (4): RNA binding (GO:0003723), microtubule binding (GO:0008017), ubiquitin binding (GO:0043130), protein binding (GO:0005515)
GO Cellular Component (9): fibrillar center (GO:0001650), nucleus (GO:0005634), nuclear envelope (GO:0005635), nuclear pore (GO:0005643), nucleoplasm (GO:0005654), cytoplasm (GO:0005737), mitotic spindle pole (GO:0097431), spindle pole (GO:0000922), cytoskeleton (GO:0005856)
Reactome top-level categories
Rollup of top-14 pathways:
| Category | Pathways |
|---|---|
| Transport of Mature mRNAs Derived from Intronless Transcripts | 3 |
| Inositol phosphate metabolism | 3 |
| Interactions of Rev with host cellular proteins | 2 |
| Influenza Infection | 2 |
| SUMO E3 ligases SUMOylate target proteins | 2 |
| Antimicrobial mechanism of IFN-stimulated genes | 1 |
| Transport of Mature Transcript to Cytoplasm | 1 |
| Late Phase of HIV Life Cycle | 1 |
| Influenza Viral RNA Transcription and Replication | 1 |
| Export of Viral Ribonucleoproteins from Nucleus | 1 |
| Glycolysis | 1 |
| Interactions of Vpr with host cellular proteins | 1 |
| Metabolism of non-coding RNA | 1 |
| Nuclear Envelope Breakdown | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 4 |
| chromosome organization | 1 |
| RNA transport | 1 |
| nuclear export | 1 |
| RNA export from nucleus | 1 |
| gene expression | 1 |
| mRNA transport | 1 |
| nuclear transport | 1 |
| cellular process | 1 |
| mitotic spindle organization | 1 |
| regulation of spindle organization | 1 |
| nucleic acid binding | 1 |
| tubulin binding | 1 |
| ubiquitin-like protein binding | 1 |
| binding | 1 |
| nucleolus | 1 |
| intracellular membrane-bounded organelle | 1 |
| nucleus | 1 |
| endomembrane system | 1 |
| organelle envelope | 1 |
| nuclear envelope | 1 |
| nuclear protein-containing complex | 1 |
| nuclear lumen | 1 |
| intracellular anatomical structure | 1 |
| spindle pole | 1 |
| mitotic spindle | 1 |
| spindle | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
2280 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RAE1 | NUP98 | P52948 | 986 |
| RAE1 | NXF1 | Q9UBU9 | 964 |
| RAE1 | GLE1 | Q53GS7 | 914 |
| RAE1 | DDX39B | Q13838 | 914 |
| RAE1 | RBM15B | Q8NDT2 | 891 |
| RAE1 | HNRNPUL1 | Q9BUJ2 | 887 |
| RAE1 | ALYREF | Q86V81 | 871 |
| RAE1 | THOC2 | Q8NI27 | 860 |
| RAE1 | KLRK1 | P26718 | 812 |
| RAE1 | NUP214 | P35658 | 804 |
| RAE1 | MAPRE2 | Q15555 | 799 |
| RAE1 | NUP42 | O15504 | 792 |
| RAE1 | NUP153 | P49790 | 775 |
| RAE1 | NXT1 | Q9UKK6 | 770 |
| RAE1 | PABPC1 | P11940 | 763 |
IntAct
157 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RAE1 | NUP98 | psi-mi:“MI:0914”(association) | 0.930 |
| NUP98 | RAE1 | psi-mi:“MI:0915”(physical association) | 0.930 |
| NUP98 | RAE1 | psi-mi:“MI:0407”(direct interaction) | 0.930 |
| NUP98 | RAE1 | psi-mi:“MI:0914”(association) | 0.930 |
| RAE1 | psi-mi:“MI:0915”(physical association) | 0.930 | |
| NUP98 | psi-mi:“MI:0914”(association) | 0.910 | |
| NUP98 | psi-mi:“MI:0915”(physical association) | 0.910 | |
| NUP98 | psi-mi:“MI:0914”(association) | 0.910 | |
| MED4 | MED19 | psi-mi:“MI:0914”(association) | 0.900 |
| SMARCB1 | ARID1A | psi-mi:“MI:0914”(association) | 0.860 |
| NUP98 | psi-mi:“MI:0914”(association) | 0.840 | |
| NUP98 | psi-mi:“MI:0915”(physical association) | 0.840 | |
| BRK1 | HSBP1 | psi-mi:“MI:0914”(association) | 0.740 |
| DYNLL1 | BLTP3B | psi-mi:“MI:0914”(association) | 0.730 |
| YWHAH | FAM83G | psi-mi:“MI:0914”(association) | 0.710 |
| RAE1 | NUMA1 | psi-mi:“MI:0915”(physical association) | 0.710 |
BioGRID (392): NUP98 (Co-crystal Structure), RAE1 (Affinity Capture-MS), RAE1 (Affinity Capture-MS), NUP214 (Affinity Capture-MS), NUP98 (Affinity Capture-MS), AGGF1 (Affinity Capture-MS), PRIM2 (Affinity Capture-MS), POLA1 (Affinity Capture-MS), BUB1B (Affinity Capture-MS), POLA2 (Affinity Capture-MS), MYCBP2 (Affinity Capture-MS), PRIM1 (Affinity Capture-MS), RAE1 (Affinity Capture-MS), RAE1 (Affinity Capture-MS), AASDHPPT (Co-fractionation)
ESM2 similar proteins: A0A1W5T363, A5DGL8, A5DVY3, A5GFN6, A8QBF3, A8WVX8, B0XFT7, B3N4C7, B4GSH1, B4I195, B4JB43, B4Q354, G0SEA3, O02195, O14301, O42937, O75083, O88342, O93277, P27133, P40066, P41838, P78406, Q16K15, Q26613, Q29L19, Q2KJH4, Q38942, Q3SWS8, Q4R6D2, Q54DM1, Q5AI86, Q5E9A4, Q5FVA9, Q5RF99, Q5RKI0, Q6CI08, Q6DIF4, Q6PAX7, Q759L2
Diamond homologs: A0A1W5T363, A5GFN6, A8IR43, G0SEA3, O42860, O43684, O60097, P40066, P41838, P78406, Q1JQB2, Q38942, Q3SWS8, Q4R6D2, Q54DM1, Q5E9A4, Q5FVA9, Q5RB58, Q5RF99, Q7ZWF0, Q8C570, Q8VYZ5, Q93454, Q9C1X1, Q9C701, Q9LJN8, Q9W2E7, Q9WVA3, Q9XWH0, Q9YGY3, S8ASK6, O43071, O93277, Q54MP8, Q5ZJW8, Q6GPU3, Q9FE91, O60907, Q4R8H1, Q95RJ9
SIGNOR signaling
5 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| RAE1 | “up-regulates activity” | NUP98 | binding |
| Interferon-type-I | “up-regulates quantity by expression” | RAE1 | “transcriptional regulation” |
| RAE1 | up-regulates | mRNA_nuclear_export | |
| 6 | “down-regulates activity” | RAE1 | binding |
| RAE1 | “form complex” | NPC | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 154 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Rev-mediated nuclear export of HIV RNA | 11 | 34.2× | 7e-12 |
| NEP/NS2 Interacts with the Cellular Export Machinery | 10 | 33.9× | 6e-11 |
| Nuclear import of Rev protein | 10 | 32.9× | 6e-11 |
| Transport of Ribonucleoproteins into the Host Nucleus | 9 | 31.5× | 9e-10 |
| IPs transport between nucleus and cytosol | 8 | 29.9× | 9e-09 |
| IP3 and IP4 transport between cytosol and nucleus | 8 | 29.9× | 9e-09 |
| IP6 and IP7 transport between cytosol and nucleus | 8 | 29.9× | 9e-09 |
| Vpr-mediated nuclear import of PICs | 9 | 29.6× | 1e-09 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| RNA export from nucleus | 6 | 43.2× | 1e-06 |
| nucleocytoplasmic transport | 9 | 27.1× | 4e-08 |
| protein export from nucleus | 5 | 19.6× | 1e-03 |
| establishment of mitotic spindle orientation | 5 | 18.5× | 1e-03 |
| mRNA export from nucleus | 7 | 15.9× | 7e-05 |
| protein import into nucleus | 12 | 13.3× | 6e-08 |
| mRNA transport | 6 | 12.2× | 2e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
23 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 22 |
| Likely benign | 0 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
2464 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:57356450:G:C | R67P | 1.000 |
| 20:57356455:T:A | W69R | 1.000 |
| 20:57356455:T:C | W69R | 1.000 |
| 20:57365404:T:A | W113R | 1.000 |
| 20:57365404:T:C | W113R | 1.000 |
| 20:57368802:T:C | L211P | 1.000 |
| 20:57373520:G:C | G230R | 1.000 |
| 20:57373521:G:A | G230D | 1.000 |
| 20:57373527:C:A | A232D | 1.000 |
| 20:57373532:G:A | G234R | 1.000 |
| 20:57373532:G:C | G234R | 1.000 |
| 20:57373533:G:A | G234E | 1.000 |
| 20:57373535:A:C | S235R | 1.000 |
| 20:57373537:T:A | S235R | 1.000 |
| 20:57373537:T:G | S235R | 1.000 |
| 20:57373541:G:A | E237K | 1.000 |
| 20:57373544:G:A | G238R | 1.000 |
| 20:57373544:G:C | G238R | 1.000 |
| 20:57373544:G:T | G238W | 1.000 |
| 20:57373545:G:A | G238E | 1.000 |
| 20:57373545:G:T | G238V | 1.000 |
| 20:57373547:A:G | R239G | 1.000 |
| 20:57373548:G:C | R239T | 1.000 |
| 20:57373548:G:T | R239I | 1.000 |
| 20:57373549:A:C | R239S | 1.000 |
| 20:57373549:A:T | R239S | 1.000 |
| 20:57373551:T:A | V240D | 1.000 |
| 20:57373553:G:C | A241P | 1.000 |
| 20:57373554:C:A | A241D | 1.000 |
| 20:57373557:T:A | I242N | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000066145 (20:57377742 G>T), RS1000151698 (20:57377516 C>T), RS1000208804 (20:57369328 T>C), RS1000286074 (20:57356907 A>T), RS1000355948 (20:57361804 G>A), RS1000406440 (20:57374257 C>A,G,T), RS1000470608 (20:57379453 G>A), RS1000547040 (20:57368404 A>G), RS1000601632 (20:57369511 G>A), RS1000714107 (20:57373061 G>A,T), RS1000755497 (20:57378577 G>A), RS1000820725 (20:57358199 G>A), RS1000899608 (20:57378251 C>T), RS1000915623 (20:57358056 T>C), RS1001103836 (20:57352095 T>A)
Disease associations
OMIM: gene MIM:603343 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL6066294 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
ChEMBL bioactivities
2 potent at pChembl≥5 of 2 total, top 2 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 8.15 | Kd | 7.018 | nM | CHEMBL5653589 |
| 8.15 | ED50 | 7.018 | nM | CHEMBL5653589 |
PubChem BioAssay actives
1 with measured affinity, of 2 total; 1 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| 4-methyl-3-[(2-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide | 2149187: Binding affinity to human RAE1 incubated for 45 mins by Kinobead based pull down assay | kd | 0.0070 | uM |
CTD chemical–gene interactions
35 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| deoxynivalenol | increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| bisphenol A | decreases expression | 1 |
| sodium arsenate | decreases expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| sodium arsenite | increases expression | 1 |
| nivalenol | increases expression | 1 |
| beta-methylcholine | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| abrine | increases expression | 1 |
| 2,2’,4,4’-tetrabromodiphenyl ether | decreases expression | 1 |
| (4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II) | increases expression | 1 |
| pentabrominated diphenyl ether 100 | increases expression | 1 |
| LDN 193189 | affects cotreatment, increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Coumestrol | increases expression | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
| Doxorubicin | increases expression | 1 |
| Enzyme Inhibitors | decreases activity, increases O-linked glycosylation | 1 |
| Ivermectin | decreases expression | 1 |
| Methotrexate | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Naled | affects expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Plant Extracts | increases expression, affects cotreatment | 1 |
| Rotenone | increases expression | 1 |
| Smoke | decreases expression | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5652229 | Binding | Binding affinity to human RAE1 incubated for 45 mins by Kinobead based pull down assay | NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.